MedTrace Logo

The STAR Prospective Clinical Series

NCT02217150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-01-20

No results posted yet for this study

Summary

Prospective clinical series to gather post tumor ablation clinical outcomes from subjects with painful spinal metastases following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.

Conditions

  • Metastasis to Vertebral Column

Sponsors & Collaborators

  • DFINE Inc.

    lead INDUSTRY

Principal Investigators

  • Sandeep Bagla, MD · Inova Alexandria Hospital

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-12-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217150 on ClinicalTrials.gov